Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, vulval itching can occur while taking Mounjaro (tirzepatide), though it isn't listed as one of its common side effects. Skin and mucosal changes are reported by some people on GLP-1 and dual-agonist medicines, and a few distinct mechanisms may explain why the vulval area feels irritated or itchy during treatment. This page works through those mechanisms clearly. Because Mounjaro is a prescription-only medicine, any new or persistent symptom should be discussed with a prescriber or GP rather than managed by guesswork — and in some cases, itching in this area points to something unrelated to the medicine entirely.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro SmPC lists pruritus (itching) as an uncommon side effect, meaning it occurs in fewer than 1 in 100 people but more than 1 in 1,000. Injection-site reactions, including localised itching around the abdomen, thigh or upper arm, are separately noted and more frequently reported. Vulval itching specifically isn't broken out in the trial data, because clinical trials typically record symptoms by category rather than by anatomical site. So the absence of 'vulval pruritus' on the label doesn't mean it isn't happening; it means it wasn't captured that granularly in the SURMOUNT programme.
If you're experiencing this symptom, you're not imagining it, and you're not alone in reporting it. Our prescribers hear about skin and mucosal changes fairly regularly from people who are a few weeks into treatment. The broader picture of itching on Mounjaro covers the general pruritus data in more detail.
The NHS patient information for tirzepatide notes that any new skin reaction should be reported to a prescriber. If itching is severe, widespread or accompanied by swelling of the face, lips or throat, treat it as a potential allergic reaction and seek urgent medical help. You can also report any suspected side effects through the MHRA's Yellow Card scheme.
This is the mechanism most people don't think to consider, and it's worth understanding. Mounjaro produces meaningful, relatively rapid weight loss in many people. That process involves significant metabolic and hormonal shifts. Oestrogen is partly stored in and metabolised by fat tissue, so as body fat decreases, oestrogen levels can fluctuate. Lower oestrogen levels are a well-known cause of vaginal dryness and vulval irritation, the same mechanism seen in perimenopause.
Separately, the change in eating pattern matters. Tirzepatide reduces appetite substantially; many people eat considerably less during the first weeks of treatment, and the composition of what they eat changes too. A drop in fibre, fermented foods or probiotic intake can disrupt the gut and vaginal microbiome. The vulvar area is sensitive to microbiome imbalance, and a shift in vaginal pH can produce itching, discharge or general discomfort that has nothing to do with the medicine's pharmacology directly.
Dehydration is another underappreciated factor. The gastrointestinal side effects of tirzepatide (nausea and diarrhoea in particular) can leave people mildly dehydrated, especially in the first month of treatment. Mucous membranes, including vaginal tissue, dry out when fluid intake lags. Staying well hydrated is one of the more straightforward things you can do to manage this. For a closer look at skin-related symptoms more broadly, the guide to itchy skin on Mounjaro is a useful companion read.
A common misconception is that any new symptom appearing after starting a medicine must be caused by that medicine. Sometimes the timing is coincidental. Thrush (vulvovaginal candidiasis) is extremely common and has its own triggers, antibiotics, hormonal fluctuations, tight clothing, soap products used near the area. Bacterial vaginosis is also common. Neither requires Mounjaro to cause it, and both are straightforwardly treatable once correctly identified.
If the itching is internal as well as external, if there is unusual discharge, or if it has persisted for more than a week or two, a GP appointment is the right move. They can take a swab and identify the cause precisely. Stopping Mounjaro is not the first step, especially without speaking to your prescriber. For specific questions about how tirzepatide affects the skin, the overview of Mounjaro and skin irritation and the explainer on whether Mounjaro makes you itchy both cover the mechanism in plain terms.
It's also worth checking what you're washing with. Soap, bubble bath and scented products applied to the vulva are among the most frequent causes of localised irritation, predating any medicine by decades of clinical observation. Switching to plain water or a fragrance-free wash can resolve symptoms within days and costs nothing to try.
First, mention it at your next clinical review. If you're being treated through a regulated service, you should have access to prescriber support between orders, at nume, that's available seven days a week. Don't wait until your repeat is due if the symptom is bothersome or worsening.
Second, think through the practical checklist: hydration, soap products, any new clothing or laundry detergent, recent antibiotic use, changes in diet. Rule out the simple things before attributing everything to tirzepatide.
Third, see your GP if the symptom is persistent, painful, or accompanied by discharge or odour. A swab is quick, conclusive, and points straight to the treatment.
If you want to understand tirzepatide more fully before or during treatment, our tirzepatide information page and the Mounjaro overview cover the medicine's mechanism, licensed use and clinical background in detail. For context on what private treatment involves, the Mounjaro cost guide explains what a legitimate prescription service includes. And if you have questions about whether you'd be a suitable candidate for treatment, the weight-loss treatment overview is a good place to start before speaking to a prescriber.
If you're ready to speak to one of our GPhC-registered prescribers about your symptoms or your suitability for treatment, check your eligibility with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.